For: | Song ZW, Pan YC, Huang ZC, Liu WX, Zhao RS, Jing HM, Dong F. Posaconazole-associated severe hyperbilirubinemia in acute myeloid leukemia following chemotherapy: A case report. World J Clin Cases 2018; 6(16): 1206-1209 [PMID: 30613684 DOI: 10.12998/wjcc.v6.i16.1206] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v6/i16/1206.htm |
Number | Citing Articles |
1 |
Rolf Teschke, Gaby Danan. Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993–Mid 2020: A Comprehensive Analysis. Medicines 2020; 7(10): 62 doi: 10.3390/medicines7100062
|
2 |
Fan Feng, Xiaojuan Li, Ruisheng Li, Boan Li. The multiple‐kinase inhibitor lenvatinib inhibits the proliferation of acute myeloid leukemia cells. Animal Models and Experimental Medicine 2019; 2(3): 178 doi: 10.1002/ame2.12076
|
3 |
Dan Liu, Qi Yu, Qing Ning, Zhongqiu Liu, Jie Song. The relationship between UGT1A1 gene & various diseases and prevention strategies. Drug Metabolism Reviews 2022; 54(1): 1 doi: 10.1080/03602532.2021.2001493
|